OncoSec Medical Inc (ONCSQ)

[erostratus]

I don't see any date listed there other than final data being mid-year, as they'd always been. Interim dates are not set, and I would still expect the MCC interim sooner.

If people really expected a partnership because they "misread" a twitter smiley face then I've lost hope for the world lol... I thought it was clear that our speculations were tongue-in-cheek at best...jesus,

OncoSec has made great progress in 2013 that has served to validate our clinical efforts and expand our visibility in the scientific community. We look forward to an excellent year ahead and will continue building on our strong fundamentals with the goal of increasing shareholder value, while delivering a meaningful benefit to patients and families impacted by cancer."

The company continues to focus on clinical development opportunities, which includes potentially initiating proprietary programs funded by third parties. The company is actively seeking additional grant funding and strategic partnerships to further develop its novel immunotherapy products.

I expect this to be realized this year, as this method is golden and too good to pass up by big pharma. Bottomline is that with continued validation of our trials, this WILL happen. its just a matter of when, and I would not put it past happening this year.

In any case, I am encouraged by this announcement, especially by their focus in expanding our manufacturing abilities, designing new prototypes, launching a new trial, reporting data for our current 3 phase 2 trials (interims, pfs, final), reporting data with dosage-increases (this I'm very eager to see) and furthering our combination immunopulse anti-PD1 goals, which I see as being of blockbuster potential.

Really I couldn't ask for a more action packed year than this. You can't find me another early-stage company this focused and eventful.


I'll take any idiotic market reaction as an opportunity to accumulate.